Cullen/Frost Bankers, Inc. (CFR.PB) stock
CFR.PBNYSENational Commercial BanksFiscal year ends December 31Also trades as CFR
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3027% above fair value
$15.26−0.20 (-1.29%)
Close on Oct 30, 2026Market cap $9.79BP/E 14.6Yield 2.51%
Cullen/Frost Bankers EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Cullen/Frost Bankers's EPS for the twelve months ending Sep 30, 2026 was $10.78, up 10.7% year over year. For fiscal 2025 it was $9.92, up 11.8% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is $9.92 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.92 | +11.8% |
| FY2024 | Dec 31, 2024 | $8.87 | -2.5% |
| FY2023 | Dec 31, 2023 | $9.10 | +3.3% |
| FY2022 | Dec 31, 2022 | $8.81 | +30.3% |
| FY2021 | Dec 31, 2021 | $6.76 | +32.5% |
| FY2020 | Dec 31, 2020 | $5.10 | -25.4% |
| FY2019 | Dec 31, 2019 | $6.84 | -0.9% |
| FY2018 | Dec 31, 2018 | $6.90 | +25.2% |
| FY2017 | Dec 31, 2017 | $5.51 | +17.2% |
| FY2016 | Dec 31, 2016 | $4.70 | +9.8% |
| FY2015 | Dec 31, 2015 | $4.28 | -0.2% |
| FY2014 | Dec 31, 2014 | $4.29 | +12.9% |
| FY2013 | Dec 31, 2013 | $3.80 | -1.6% |
| FY2012 | Dec 31, 2012 | $3.86 | +9.0% |
| FY2011 | Dec 31, 2011 | $3.54 | +2.9% |
| FY2010 | Dec 31, 2010 | $3.44 | +14.7% |
| FY2009 | Dec 31, 2009 | $3.00 | -14.3% |
| FY2008 | Dec 31, 2008 | $3.50 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.84 | +6.4% |
| Q2 FY2026 | Jun 30, 2026 | $2.70 | +13.0% |
| Q1 FY2026 | Mar 31, 2026 | $2.65 | +15.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.59 | +8.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.67 | +19.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.39 | +8.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.30 | +11.7% |
| Q4 FY2024 | Dec 31, 2024 | $2.38 | +51.6% |
| Q3 FY2024 | Sep 30, 2024 | $2.24 | -5.9% |
| Q2 FY2024 | Jun 30, 2024 | $2.21 | -10.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.06 | -23.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.57 | -46.4% |
| Q3 FY2023 | Sep 30, 2023 | $2.38 | -8.1% |
| Q2 FY2023 | Jun 30, 2023 | $2.47 | +36.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.70 | +80.0% |
| Q4 FY2022 | Dec 31, 2022 | $2.93 | +90.3% |
| Q3 FY2022 | Sep 30, 2022 | $2.59 | +57.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.81 | +0.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.50 | -15.3% |
| Q4 FY2021 | Dec 31, 2021 | $1.54 | +10.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.65 | +10.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.80 | +22.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.77 | +136.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.40 | -13.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.50 | -13.3% |
| Q2 FY2020 | Jun 30, 2020 | $1.47 | -14.5% |
| Q1 FY2020 | Mar 31, 2020 | $0.75 | -58.1% |
| Q4 FY2019 | Dec 31, 2019 | $1.61 | -11.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.73 | -2.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.72 | +2.4% |
| Q1 FY2019 | Mar 31, 2019 | $1.79 | +11.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.82 | +19.0% |
| Q3 FY2018 | Sep 30, 2018 | $1.78 | +26.2% |
| Q2 FY2018 | Jun 30, 2018 | $1.68 | +30.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.61 | +25.8% |
| Q4 FY2017 | Dec 31, 2017 | $1.53 | +20.5% |
| Q3 FY2017 | Sep 30, 2017 | $1.41 | – |
| Q2 FY2017 | Jun 30, 2017 | $1.29 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.28 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.27 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics